Wilmington Savings Fund Society FSB Boosts Holdings in Cigna Group $CI

Wilmington Savings Fund Society FSB raised its holdings in shares of Cigna Group (NYSE:CI) by 3.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,740 shares of the health services provider’s stock after buying an additional 561 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Cigna Group were worth $5,203,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of CI. Flaharty Asset Management LLC bought a new stake in Cigna Group during the first quarter valued at about $28,000. 1248 Management LLC bought a new position in shares of Cigna Group during the 1st quarter valued at approximately $29,000. Activest Wealth Management increased its holdings in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after acquiring an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC raised its stake in Cigna Group by 74.1% during the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after acquiring an additional 43 shares during the period. Finally, Saudi Central Bank purchased a new position in Cigna Group during the first quarter valued at approximately $36,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 2.2%

Shares of CI stock opened at $301.91 on Wednesday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $80.59 billion, a price-to-earnings ratio of 16.48, a price-to-earnings-growth ratio of 0.87 and a beta of 0.45. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88. The stock’s 50-day moving average price is $295.86 and its 200-day moving average price is $308.87.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. During the same period in the prior year, the company earned $6.72 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were given a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group’s dividend payout ratio is 32.97%.

Analyst Ratings Changes

A number of analysts have recently issued reports on CI shares. Royal Bank Of Canada reissued an “outperform” rating and issued a $371.00 price objective on shares of Cigna Group in a research note on Thursday, June 26th. Guggenheim reiterated a “buy” rating and issued a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research note on Monday, August 4th. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Cantor Fitzgerald reiterated an “overweight” rating and set a $365.00 target price on shares of Cigna Group in a research report on Tuesday, August 26th. Finally, Robert W. Baird set a $372.00 target price on Cigna Group in a research note on Thursday, August 14th. Two research analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $372.53.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the sale, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the sale, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. The trade was a 9.49% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.